BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23411967)

  • 1. [A case with multiple liver metastases from rectal cancer responding completely to FOLFOX for a long duration without exacerbation of peripheral neuropathy].
    Nakae S; Mizojiri G; Fujikawa M; Ishida J; Yamamoto M; Harada N; Haji S; Toyoda M; Senzaki H
    Gan To Kagaku Ryoho; 2013 Feb; 40(2):255-8. PubMed ID: 23411967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of metastatic colorectal cancer with icterus due to multiple liver metastases treated effectively by FOLFOX plus bevacizumab].
    Terasawa T; Koja S; Yasuda K; Fukuda K
    Gan To Kagaku Ryoho; 2013 Aug; 40(8):1115-8. PubMed ID: 23986063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4) as salvage chemotherapy in patients with pretreated colorectal cancer.
    Shitara K; Munakata M; Muto O; Kasai M; Okada R; Mitobe S; Sakata Y
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1079-84. PubMed ID: 17637544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Two cases of interstitial pneumonia caused by cetuximab plus mFOLFOX6 therapy in metastatic colorectal cancer patients].
    Shioiri M; Hasegawa M; Tanaka H; Toura I; Kudo S; Sato K; Inoue K; Nakanishi T; Nishiyama S; Takebe S; Ogino Y; Ohsaki S; Nagashima Y
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2198-200. PubMed ID: 23268022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of advanced rectal cancer with severe liver dysfunction due to multiple liver metastases].
    Higuchi T; Ishikawa T; Tsukamoto S; Fujimori Y; Oda G; Okazaki S; Ishiguro M; Kobayashi H; Iida S; Uetake H; Yasuno M; Enomoto M; Sugihara K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2181-3. PubMed ID: 20037363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOLFOX plus cetuximab for a patient with metastatic colorectal cancer with icterus due to multiple liver metastases.
    Mizota A; Shitara K; Kondo C; Nomura M; Yokota T; Takahari D; Ura T; Muro K
    Gan To Kagaku Ryoho; 2011 Jul; 38(7):1205-8. PubMed ID: 21772113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of metastatic rectal cancer in an extremely aged patient successfully treated with mFOLFOX6 plus bevacizumab].
    Yokoyama M; Urakawa M; Murakami T; Amano K; Ohsawa T; Okada N; Kumamoto K; Ishibashi K; Ishida H
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2241-3. PubMed ID: 22202342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of rectal cancer with liver metastases successfully treated with modified FOLFOX6 therapy].
    Shoji T; Takahashi Y; Matsuda I; Suzuki K; Misumi K; Taniguchi M; Yamazaki M; Yonekawa H
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1579-81. PubMed ID: 19755838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of rectal cancer with synchronous multiple liver metastases successfully treated with combined chemotherapy of modified FOLFOX6 and bevacizumab].
    Tokunou K; Yamamoto T; Toshimitsu H; Kitamura Y; Andou S; Tsushimi K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2626-8. PubMed ID: 21224660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
    Yamada Y; Ohtsu A; Boku N; Miyata Y; Shimada Y; Doi T; Muro K; Muto M; Hamaguchi T; Mera K; Yano T; Tanigawara Y; Shirao K
    Jpn J Clin Oncol; 2006 Apr; 36(4):218-23. PubMed ID: 16684860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case report of a patient with advanced rectal cancer who was administered chemotherapy in collaboration with a clinical pathway and visiting nursing care].
    Iwata S; Imai S; Mochiduki H; Watanabe K; Imazeki M; Ueno M; Kaneko J; Komatsu Y; Taguchi Y; Watanabe Y; Hirata K; Suzuki C
    Gan To Kagaku Ryoho; 2006 Dec; 33 Suppl 2():361-3. PubMed ID: 17469387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Huge unresectable multiple hepatic metastases of rectum cancer responding to combined therapy with FOLFIRI +bevacizumab - a case report].
    Tagami Y; Ogata S; Katakawa M; Bando Y
    Gan To Kagaku Ryoho; 2012 Feb; 39(2):317-9. PubMed ID: 22333652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H; Ozaki T; Shiina M
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Successful treatment with cetuximab combination chemotherapy in a case of FOLFOX-refractory rectal cancer with previously unresectable multiple liver metastases leading to complete resection].
    Mitsuhashi K; Matsusaka S; Mizunuma N; Ichimura T; Ozaka M; Ogura M; Shinozaki E; Suenaga M; Chin K; Fujimoto Y; Saiura A; Yamamoto N; Hatake K
    Gan To Kagaku Ryoho; 2010 Nov; 37(11):2203-7. PubMed ID: 21084828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of liver metastasis of rectal cancer demonstrating complete response for more than two years to mFOLFOX6].
    Miyo M; Kato T; Miyake Y; Kato A; Sakamoto T; Doi T; Hoshi M; Makari Y; Oshima S; Iijima S; Kurokawa E; Kikkawa N
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2160-2. PubMed ID: 20037356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
    Del Freo A; Fiorentini G; Sanguinetti F; Muttini MP; Pennucci C; Mambrini A; Pacetti P; Della Seta R; Lombardi M; Torri T; Cantore M
    In Vivo; 2006; 20(6A):743-6. PubMed ID: 17203759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.
    Boxberger F; Albrecht H; Konturek PC; Reulbach U; Maennlein G; Meyer T; Hohenberger W; Hahn EG; Wein A
    Med Sci Monit; 2010 Feb; 16(2):CR49-55. PubMed ID: 20110914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity.
    Milla P; Airoldi M; Weber G; Drescher A; Jaehde U; Cattel L
    Anticancer Drugs; 2009 Jun; 20(5):396-402. PubMed ID: 19287306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A Case of Radical Resection of Rectal Cancer with Multiple Liver and Lung Metastases after Preoperative Chemotherapy].
    Yamashita S; Shimizu Y; Tominaga H; Kimura Y; Odagiri K; Kurokawa T; Yamaguchi M; Takahashi G; Sawada G; Moon J; Inoue M; Irei T; Nakahira S; Hatanaka N
    Gan To Kagaku Ryoho; 2015 Oct; 42(10):1274-6. PubMed ID: 26489570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
    Ducreux M; Ychou M; Laplanche A; Gamelin E; Lasser P; Husseini F; Quenet F; Viret F; Jacob JH; Boige V; Elias D; Delperro JR; Luboinski M;
    J Clin Oncol; 2005 Aug; 23(22):4881-7. PubMed ID: 16009952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.